Transforming Health with Precision
Preserving Legacy with Purpose.
Shinlaza Inc. — a North American life sciences company dedicated to pharmaceutical manufacturing, natural health, and regulatory excellence.
Our Story
Rooted in Legacy,
Driven by Innovation.
Purity
Uncompromising quality in every formulation, from raw material sourcing to final product release.
Precision
Pharmaceutical-grade processes at every stage of development and manufacturing.
Purpose
Driven by legacy, guided by science — creating solutions that empower the human body to heal.
SHINLAZA derives its name from the uniting of two family legacies — Shino and Lazar — symbolizing strength, compassion, and the pursuit of purpose across generations.
Built upon these principles, SHINLAZA stands as a modern life sciences and wellness company committed to transforming health through evidence-based innovation, ethical manufacturing, and integrative research.
Founded on the belief that healing begins with purity, our work bridges the precision of pharmaceutical science with the integrity of natural medicine. Each formulation, process, and partnership reflects a dedication to uncompromising quality, transparency, and sustainability.
At SHINLAZA, we see health not as a destination, but as an evolving journey of renewal. Guided by our core mission — to create solutions that empower the human body to heal, adapt, and thrive — we continue to develop high-impact products and programs that embody both scientific excellence and human care.
Certifications & Compliance — In Progress
Our Core Divisions
Four Integrated Verticals.
From sterile pharmaceutical production to natural health innovation and global regulatory support — all under one roof.
Sterile Injectables
High-quality vial, ampoule, and injectable production in GMP-compliant environments for domestic and global supply chains.
Nutraceuticals & Natural Health
Premium botanical, vitamin, and integrative health formulations — encapsulated and tested to pharmaceutical-grade standards.
Contract Manufacturing
End-to-end capsule, liquid, and powder product production with private label, white label, and full packaging capabilities.
Regulatory & Dossier Services
Development and submission of compliant regulatory files for Health Canada, FDA, COFEPRIS, and other international bodies.
Critical Response Program
Global Drug Shortage Response.
Shinlaza Inc. responds to critical drug shortages across North America and beyond. With capsule "0" manufacturing capacity and a rapid onboarding process, we support those facing supply disruptions.
Governments & Ministries of Health
Emergency procurement support for national drug shortage programs. We work directly with public health authorities to ensure rapid, compliant supply.
Clinics & Hospitals
Capsule-grade manufacturing with rapid onboarding. Our sterile and encapsulated production systems are designed to scale with urgency.
Pharmacies & Distributors
Private and white-label supply solutions for distributors facing critical supply disruptions across North America and internationally.
Emergency / Recall Line
For urgent non-life-threatening pharmaceutical recalls or emergencies. For life-threatening emergencies, dial 911.
Global Operations
Operating Across
Three Continents.
With regional offices across Canada, the United States, and Mexico, Shinlaza maintains a strong North American presence with global reach. Reachable 24/7 at +1 (800) 206-0051.
Mississauga, ON
Ottawa, ON
Brampton, ON
Naples, FL (Regulatory Desk)
Wilmington, DE
The Woodlands, TX
Cancún, Q.R.
Regulatory & Dossier Services
Navigating Global Compliance.
Expert guidance through complex regulatory landscapes. We develop and submit compliant regulatory files for international health authorities.
Health Canada
Full dossier preparation and submission for NDS, ANDS, and Natural Health Product applications under Health Canada's regulatory framework.
FDA (United States)
IND, NDA, ANDA, and 510(k) submission support. Comprehensive regulatory strategy for U.S. market entry.
COFEPRIS (Mexico)
Registration and compliance support for pharmaceutical and natural health products in the Mexican market under COFEPRIS guidelines.
Additional Regulatory Services
Beyond primary market submissions, our regulatory team provides gap analysis, post-market surveillance support, labelling compliance, and international dossier adaptation for emerging markets in the UAE, Australia, and Africa.
Latest news
March 2026
Company News
Shinlaza Expands Regional Office Network to Seven U.S. Locations
As part of our continued growth strategy, Shinlaza has established new regional offices in Henderson, NV and Naples, FL to better serve our U.S. partners and clients.
February 2026
Drug Shortage Response
Shinlaza Activates Emergency Supply Protocol for North American Shortage
In response to a critical shortage affecting multiple therapeutic categories, Shinlaza has activated its emergency manufacturing and distribution protocol to support affected healthcare systems.
January 2026
Regulatory
Regulatory Dossier Services Now Available for UAE and Australian Markets
Shinlaza's regulatory team has expanded its dossier preparation capabilities to include submissions for the UAE Ministry of Health and Australia's TGA.
Contact Us
Get in Touch.
Canada (Primary)
2425 Matheson Blvd E 8th Floor
Mississauga, ON L4W 5K4
United States (Regulatory Desk)
4851 Tamiami Trl N STE 200
Naples, FL 34103
Mexico
Blvd. Kukulcan 9, Punta Cancun
Cancún, Q.R., Mexico